{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:05:07Z","timestamp":1790247907209,"version":"4.1.0"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Phosphorylation is a reversible post-translational modification that dynamically regulates immune responses by reshaping the antigen profiles. Phosphoproteomics and immunopeptidomics studies reveal that phosphorylated peptides (phosphopeptides) are naturally processed and presented by MHC class I and II molecules and can elicit robust T-cell responses. These epitopes influence proteasome cleavage, TAP transport, and MHC loading, defining the immunopeptidome under physiological and pathological states. Structurally, phosphate groups enhance MHC binding and immunogenicity, positioning phosphorylated neoantigens as promising targets for cancer immunotherapy and vaccine development. Beyond adaptive immunity, phosphorylation regulates innate signaling through Toll-like receptors (TLRs) and antigen-presenting cell activation, linking post-translational modifications to immune plasticity. Infections by parasites and bacteria such as\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    exploit phosphoregulation to evade antigen presentation, revealing conserved mechanisms of immune modulation. Integrating phosphoproteomic data with immune profiling may uncover new biomarkers and therapeutic strategies. This review summarizes how phosphorylation shapes antigen presentation and immune recognition across cancer, infection, and inflammation, and outlines future directions for phosphoantigen-based immunotherapy.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1824717","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T10:01:16Z","timestamp":1786528876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphorylation shapes antigen presentation and immune recognition: mechanistic insights and translational perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Ramesh","family":"Rijal","sequence":"first","affiliation":[{"name":"School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi","place":["Hattiesburg, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre F.","family":"Marques","sequence":"additional","affiliation":[{"name":"School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi","place":["Hattiesburg, MS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16304","article-title":"Protein tyrosine phosphatases as emerging targets for cancer immunotherapy","volume":"183","author":"Qu","year":"2026","journal-title":"Br J Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-020-00421-2","article-title":"Targeting ubiquitin signaling for cancer immunotherapy","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010134","article-title":"The role of antigen processing and presentation in cancer and the efficacy of immune checkpoint inhibitor immunotherapy","volume":"13","author":"Mpakali","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1660","article-title":"Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self","volume":"9","author":"Mohammed","year":"2008","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.12.1755","article-title":"Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo","volume":"192","author":"Zarling","year":"2000","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.100971","article-title":"Identification of post-translationally modified MHC class I-associated peptides as potential cancer immunotherapeutic targets","volume":"24","author":"Mahoney","year":"2025","journal-title":"Mol Cell Proteomics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903852106","article-title":"Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy","volume":"106","author":"Depontieu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100112","article-title":"MHC phosphopeptides: promising targets for immunotherapy of cancer and other chronic diseases","volume":"20","author":"Mahoney","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.08.527552","article-title":"The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles","volume":"11","author":"Molvi","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812901106","article-title":"Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes","volume":"106","author":"Petersen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577823","article-title":"MPL adjuvant contains competitive antagonists of human TLR4","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00064.2017","article-title":"Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway","volume":"313","author":"Watts","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1177\/1753425914564172","article-title":"Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS","volume":"21","author":"Stark","year":"2015","journal-title":"Innate Immun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127413","article-title":"The success of toll-like receptor 4 based vaccine adjuvants","volume":"61","author":"Carter","year":"2025","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4147\/hto-080300","article-title":"Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer","volume":"2","author":"Monie","year":"2008","journal-title":"Biologics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2009.069","article-title":"The peptide-loading complex--antigen translocation and MHC class I loading","volume":"390","author":"Scholz","year":"2009","journal-title":"Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m003617200","article-title":"Regulation of transporter associated with antigen processing by phosphorylation","volume":"275","author":"Li","year":"2000","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3289","article-title":"Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis","volume":"18","author":"Guo","year":"2016","journal-title":"Nat Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.m113.037374","article-title":"An unbiased proteomic screen reveals caspase cleavage is positively and negatively regulated by substrate phosphorylation","volume":"13","author":"Turowec","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0657-y","article-title":"The role of the proteasome in the generation of MHC class I ligands and immune responses","volume":"68","author":"Sijts","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10254-003-0010-4","article-title":"The components of the proteasome system and their role in MHC class I antigen processing","volume":"148","author":"Kruger","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2020.10.025","article-title":"Global and site-specific effect of phosphorylation on protein turnover","volume":"56","author":"Wu","year":"2021","journal-title":"Dev Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.7.3812","article-title":"Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL","volume":"163","author":"Andersen","year":"1999","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01738.x","article-title":"The MHC class I antigen presentation pathway: strategies for viral immune evasion","volume":"110","author":"Hewitt","year":"2003","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"DhatChinamoorthy","year":"2021","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-23-0931","article-title":"Immunoproteasome activation expands the MHC class I immunopeptidome, unmasks neoantigens, and enhances T-cell anti-myeloma activity","volume":"23","author":"Rana","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coi.2017.03.015","article-title":"The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation","volume":"46","author":"Grotzke","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104013","article-title":"Phosphosite-dependent presentation of dual phosphorylated peptides by MHC class I molecules","volume":"25","author":"Zhao","year":"2022","journal-title":"iScience"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.861609","article-title":"Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; implications for immune recognition","volume":"10","author":"Sandalova","year":"2022","journal-title":"Front Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jmb.2010.04.037","article-title":"Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells","volume":"399","author":"Li","year":"2010","journal-title":"J Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.21203\/rs.3.rs-2327641\/v1","article-title":"Molecular mechanism of phosphopeptide neoantigen immunogenicity","volume":"14","author":"Patskovsky","year":"2023","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1936-0_12","article-title":"Immunopeptidomic analysis of the phosphopeptidome displayed by HLA class I molecules","volume":"2420","author":"Marcilla","year":"2022","journal-title":"Methods Mol Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.33696\/cancerimmunol.6.094","article-title":"Phosphopeptide neoantigens as emerging targets in cancer immunotherapy","volume":"6","author":"Apoorvi","year":"2024","journal-title":"J Cancer Immunol (Wilmington)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12070717","article-title":"Development and clinical applications of therapeutic cancer vaccines with individualized and shared neoantigens","volume":"12","author":"Hao","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000262","article-title":"MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma","volume":"8","author":"Engelhard","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151624","article-title":"A TCR mimic monoclonal antibody reactive with the \"public\" phospho-neoantigen pIRS2\/HLA-A*02:01 complex","volume":"7","author":"Dao","year":"2022","journal-title":"JCI Insight"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(17)49904-2","article-title":"The structural basis of T-cell receptor (TCR) activation: an enduring enigma","volume":"295","author":"Mariuzza","year":"2020","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.v32.i4.50","article-title":"Cross-reactivity of T cells and its role in the immune system","volume":"32","author":"Petrova","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.012","article-title":"Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor","volume":"28","author":"Teague","year":"2008","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-024-03195-5","article-title":"Focusing on CD8(+) T-cell phenotypes: improving solid tumor therapy","volume":"43","author":"Yao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700744","article-title":"Emerging concepts in TCR specificity: rationalizing and (maybe) predicting outcomes","volume":"199","author":"Singh","year":"2017","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010068","article-title":"TCR recognition of peptide-MHC-I: rule makers and breakers","volume":"22","author":"Szeto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2303799","article-title":"Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies","volume":"20","author":"Aparicio","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.11.005","article-title":"The dichotomous role of immunoproteasome in cancer: Friend or foe","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235632","article-title":"Targeting proteasomes and the MHC class I antigen presentation machinery to treat cancer, infections and age-related diseases","volume":"15","author":"Rana","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.smim.2023.101738","article-title":"Under pressure\" - How fungi evade, exploit, and modulate cells of the innate immune system","volume":"66","author":"Lange","year":"2023","journal-title":"Semin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.4049\/jimmunol.212.supp.1438.4569","article-title":"Molecular mimicry in pathogen immune evasion","volume":"212","author":"Santambrogio","year":"2024","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1178","article-title":"Potential clinical implications of molecular mimicry-induced autoimmunity","volume":"12","author":"Suliman","year":"2024","journal-title":"Immun Inflammation Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"203ra125","DOI":"10.1126\/scitranslmed.3006061","article-title":"MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia","volume":"5","author":"Cobbold","year":"2013","journal-title":"Sci Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.06.002","article-title":"Tyrosine phosphorylation in toll-like receptor signaling","volume":"25","author":"Chattopadhyay","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1177\/0022034510381264","article-title":"TLR-signaling networks: An integration of adaptor molecules, kinases, and cross-talk","volume":"90","author":"Brown","year":"2011","journal-title":"J Dent Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/msb.2010.29","article-title":"The phosphoproteome of toll-like receptor-activated macrophages","volume":"6","author":"Weintz","year":"2010","journal-title":"Mol Syst Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00693-9","article-title":"Phosphatases in toll-like receptors signaling: The unfairly-forgotten","volume":"19","author":"Lannoy","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121385119","article-title":"IRF3 inhibits nuclear translocation of NF-kappaB to prevent viral inflammation","volume":"119","author":"Popli","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01325","article-title":"Costimulatory molecules and immune checkpoints are differentially expressed on different subsets of dendritic cells","volume":"10","author":"Carenza","year":"2019","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: The key to more effective vaccines","volume":"9","author":"Ho","year":"2018","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7010.1","article-title":"Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells","volume":"4","author":"Ma","year":"2015","journal-title":"F1000Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.immuni.2016.07.022","article-title":"Phosphoproteomic analyses of interleukin 2 signaling reveal integrated JAK kinase-dependent and -independent networks in CD8(+) T cells","volume":"45","author":"Ross","year":"2016","journal-title":"Immunity"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int J Mol Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00335","article-title":"Intracellular transport routes for MHC I and their relevance for antigen cross-presentation","volume":"6","author":"Adiko","year":"2015","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"274","DOI":"10.20892\/j.issn.2095-3941.2023.0395","article-title":"Neoantigen cancer vaccines: A new star on the horizon","volume":"21","author":"Li","year":"2023","journal-title":"Cancer Biol Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41541-025-01118-9","article-title":"Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer","volume":"10","author":"Shah","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000003708","article-title":"Neoantigen-driven personalized tumor therapy: An update from discovery to clinical application","volume":"138","author":"Xie","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091674","article-title":"Deciphering the role of BCAR3 in cancer progression: Gene regulation, signal transduction, and therapeutic implications","volume":"16","author":"Moon","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-0043","article-title":"MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer","volume":"74","author":"Zarling","year":"2014","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40425-019-0625-x","article-title":"A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients","volume":"7","author":"Melssen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B76","unstructured":"Evaluation of a multi-phosphopeptide vaccine plus polyICLC in participants with high risk and advanced Malignancies (Mel59)\n          \n          \n            \n              Slingluff\n              JCL\n            \n          \n          \n          2016"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2023.117066","article-title":"Mass spectrometry-based phosphoproteomics in clinical applications","volume":"163","author":"Wu","year":"2023","journal-title":"Trends Analyt Chem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s42485-021-00066-x","article-title":"Digging deeper into the immunopeptidome: Characterization of post-translationally modified peptides presented by MHC I","volume":"12","author":"Mangalaparthi","year":"2021","journal-title":"J Proteins Proteom"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030683","article-title":"Adoptive cell therapy-harnessing antigen-specific T cells to target solid tumours","volume":"12","author":"Chrusciel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13060588","article-title":"Next-generation vaccine platforms: Integrating synthetic biology, nanotechnology, and systems immunology for improved immunogenicity","volume":"13","author":"Eslami","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1038\/s41467-024-51274-0","article-title":"Fast and deep phosphoproteome analysis with the Orbitrap Astral mass spectrometer","volume":"15","author":"Lancaster","year":"2024","journal-title":"Nat Commun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2021.1976152","article-title":"Phosphoproteomics: A valuable tool for uncovering molecular signaling in cancer cells","volume":"18","author":"Gerritsen","year":"2021","journal-title":"Expert Rev Proteomics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40425-017-0243-4","article-title":"Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy","volume":"5","author":"Gnjatic","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00028","article-title":"Impact of phosphoproteomics in the era of precision medicine for prostate cancer","volume":"8","author":"Ramroop","year":"2018","journal-title":"Front Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061485","article-title":"Engineering strategies to enhance TCR-based adoptive T cell therapy","volume":"9","author":"Rath","year":"2020","journal-title":"Cells"},{"key":"B86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trecan.2020.09.002","article-title":"The anticancer potential of T cell receptor-engineered T cells","volume":"7","author":"Ecsedi","year":"2021","journal-title":"Trends Cancer"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158035","article-title":"Combining cancer vaccines with immunotherapy: Establishing a new immunological approach","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/jci88590","article-title":"MHC class I-associated peptides derive from selective regions of the human genome","volume":"126","author":"Pearson","year":"2016","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.64898\/2026.03.06.710184","article-title":"Mapping the modification landscape of MHC-I epitopes: A framework for immunogenic peptidomimetic antigen design","author":"Newkirk","year":"2026","journal-title":"bioRxiv"},{"key":"B90","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/mcp.tir119.001641","article-title":"Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands","volume":"19","author":"Solleder","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1038\/s41467-018-05288-0","article-title":"Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/acs.jproteome.0c00386","article-title":"Mild acid elution and MHC immunoaffinity chromatography reveal similar albeit not identical profiles of the HLA class I immunopeptidome","volume":"20","author":"Sturm","year":"2021","journal-title":"J Proteome Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/mas.21905","article-title":"Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrain","volume":"44","author":"Flender","year":"2025","journal-title":"Mass Spectrom Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202400087","article-title":"Advancements in global phosphoproteomics profiling: Overcoming challenges in sensitivity and quantification","volume":"25","author":"Muneer","year":"2025","journal-title":"Proteomics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100104","article-title":"Quantitative consequences of protein carriers in immunopeptidomics and tyrosine phosphorylation MS(2) analyses","volume":"20","author":"Stopfer","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1080\/15419060601077917","article-title":"Methodologies for characterizing phosphoproteins by mass spectrometry","volume":"13","author":"Gafken","year":"2006","journal-title":"Cell Commun Adhes"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1586\/14789450.2015.1078730","article-title":"Recent findings and technological advances in phosphoproteomics for cells and tissues","volume":"12","author":"von Stechow","year":"2015","journal-title":"Expert Rev Proteomics"},{"key":"B98","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acs.analchem.5b04123","article-title":"Phosphoproteomics in the age of rapid and deep proteome profiling","volume":"88","author":"Riley","year":"2016","journal-title":"Anal Chem"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1111-z","article-title":"Enrichment techniques employed in phosphoproteomics","volume":"43","author":"Fila","year":"2012","journal-title":"Amino Acids"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132047","article-title":"Comprehensive evaluation of different TiO(2)-based phosphopeptide enrichment and fractionation methods for phosphoproteomics","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.a110.006452","article-title":"Enhancing the identification of phosphopeptides from putative basophilic kinase substrates using Ti (IV) based IMAC enrichment","volume":"10","author":"Zhou","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179564","article-title":"Crucial parameters for immunopeptidome characterization: A systematic evaluation","volume":"25","author":"Juanes-Velasco","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107266","article-title":"Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins","volume":"14","author":"ElAbd","year":"2023","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100823","article-title":"Innovations toward immunopeptidomics","volume":"23","author":"Abelin","year":"2024","journal-title":"Mol Cell Proteomics"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101708","article-title":"Contemplating immunopeptidomes to better predict them","volume":"66","author":"Gfeller","year":"2023","journal-title":"Semin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-024-00482-x","article-title":"Immunopeptidomics for autoimmunity: Unlocking the chamber of immune secrets","volume":"11","author":"Arshad","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16952","article-title":"The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status","volume":"8","author":"Mohammed","year":"2017","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.08.013","article-title":"Advancing human leukocyte antigen-based cancer immunotherapy: From personalized to broad-spectrum strategies for genetically heterogeneous populations","volume":"11","author":"Oseni","year":"2025","journal-title":"Trends Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03240-y","article-title":"Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab","volume":"30","author":"Alban","year":"2024","journal-title":"Nat Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40291-026-00842-9","article-title":"Neoantigen targeting as a novel approach for therapy-resistant tumors","volume":"30","author":"Okada","year":"2026","journal-title":"Mol Diagn Ther"},{"key":"B111","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2019.12.031","article-title":"Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma","volume":"182","author":"Gillette","year":"2020","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102756","article-title":"A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights","volume":"7","author":"Wang","year":"2026","journal-title":"Cell Rep Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s562997","article-title":"Phosphorylation modifications and their role in viral pneumonia: Mechanisms and therapeutic implications","volume":"18","author":"Wang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095127","article-title":"Phosphoproteomics unravel HBV triggered rewiring of host phosphosignaling events","volume":"23","author":"Lim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415803","article-title":"Implications of post-translational modifications in autoimmunity with emphasis on citrullination, homocitrullination and acetylation for the pathogenesis, diagnosis and prognosis of rheumatoid arthritis","volume":"23","author":"Haro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501766","article-title":"Post-translational modified neoantigens in autoimmune diseases: Challenges of immune tolerance","volume":"12","author":"Zhai","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17213506","article-title":"Antigenic dark matter: Unexplored post-translational modifications of tumor-associated and tumor-specific antigens in pancreatic cancer","volume":"17","author":"Safa","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100230","article-title":"MHC class I immunopeptidome: Past, present, and future","volume":"21","author":"Yewdell","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1540431","article-title":"Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response","volume":"16","author":"Balakrishnan","year":"2025","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/s41467-020-16588-9","article-title":"Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4\/6 inhibition","volume":"11","author":"Stopfer","year":"2020","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/bs.mcb.2023.06.005","article-title":"Neoantigen identification: Technological advances and challenges","volume":"183","author":"Pu","year":"2024","journal-title":"Methods Cell Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600582","article-title":"Pan-specific prediction of peptide-MHC class I complex stability, a correlate of T cell immunogenicity","volume":"197","author":"Rasmussen","year":"2016","journal-title":"J Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902107","article-title":"Peptide-MHC class II complex stability governs CD4 T cell clonal selection","volume":"184","author":"Baumgartner","year":"2010","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13071-024-06454-8","article-title":"Comparative analysis of phosphorylated proteomes between plerocercoid and adult Spirometra mansoni reveals phosphoproteomic profiles of the medical tapeworm","volume":"17","author":"Liu","year":"2024","journal-title":"Parasit Vectors"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1038\/ncomms8285","article-title":"Phosphoproteomics reveals malaria parasite protein kinase G as a signalling hub regulating egress and invasion","volume":"6","author":"Alam","year":"2015","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1138571","article-title":"Sec22b-dependent antigen cross-presentation is a significant contributor of T cell priming during infection with the parasite Trypanosoma cruzi","volume":"11","author":"Biscari","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003449","article-title":"Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite","volume":"9","author":"Feliu","year":"2013","journal-title":"PloS Pathog"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2018.1468754","article-title":"Understanding Leishmania parasites through proteomics and implications for the clinic","volume":"15","author":"Sundar","year":"2018","journal-title":"Expert Rev Proteomics"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803458","article-title":"Autophagy and its role in MHC-mediated antigen presentation","volume":"182","author":"Crotzer","year":"2009","journal-title":"J Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.64898\/2026.02.25.707907","article-title":"Dynamic phosphoproteomics and proteomics uncover Leishmania donovani-driven ferritin hijacking, contributing to the control of iron homeostasis and iron-related oxidative stress","author":"Shintre","year":"2026","journal-title":"bioRxiv"},{"key":"B133","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2007.04.043","article-title":"Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin","volume":"130","author":"Jayachandran","year":"2007","journal-title":"Cell"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800530","article-title":"Mycobacterial PknG targets the Rab7l1 signaling pathway to inhibit phagosome-lysosome fusion","volume":"201","author":"Pradhan","year":"2018","journal-title":"J Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409716102","article-title":"Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis","volume":"102","author":"Vergne","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109201108","article-title":"Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H+-ATPase to inhibit phagosome acidification","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2001.00127.x","article-title":"Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: Correlation with impaired translocation of PKCalpha and defective phagosome maturation","volume":"3","author":"Holm","year":"2001","journal-title":"Cell Microbiol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2010.11.005","article-title":"Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence","volume":"8","author":"Fentress","year":"2010","journal-title":"Cell Host Microbe"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.8.4487-4497.2003","article-title":"The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2","volume":"71","author":"Gehring","year":"2003","journal-title":"Infect Immun"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.10.020","article-title":"IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway","volume":"48","author":"Park","year":"2011","journal-title":"Mol Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0319OC","article-title":"IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages","volume":"45","author":"O'Leary","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.04.045","article-title":"Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3","volume":"473","author":"Duan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737902","article-title":"Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes","volume":"38","author":"Thibodeau","year":"2008","journal-title":"Eur J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.682708","article-title":"Interleukin 10 (IL-10)-mediated immunosuppression: MARCH-I induction regulates antigen presentation by macrophages but not dendritic cells","volume":"290","author":"Mittal","year":"2015","journal-title":"J Biol Chem"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000213","article-title":"Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases","volume":"2","author":"Gomez","year":"2009","journal-title":"Sci Signal"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000305","article-title":"Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif","volume":"2","author":"Abu-Dayyeh","year":"2008","journal-title":"PloS NeglTrop Dis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fimmu.2014.00203","article-title":"Metabolic control of dendritic cell activation and function: Recent advances and clinical implications","volume":"5","author":"Everts","year":"2014","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.009","article-title":"mTOR-mediated regulation of dendritic cell differentiation and function","volume":"37","author":"Sukhbaatar","year":"2016","journal-title":"Trends Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00868","article-title":"Increased Akt-driven glycolysis is the basis for the higher potency of CD137L-DCs","volume":"10","author":"Zeng","year":"2019","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01274-22","article-title":"Glutamine is required for M1-like polarization of macrophages in response to Mycobacterium tuberculosis infection","volume":"13","author":"Jiang","year":"2022","journal-title":"mBio"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.7554\/elife.39169","article-title":"Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages","volume":"7","author":"Cumming","year":"2018","journal-title":"Elife"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12394","article-title":"Immunometabolism of leishmania granulomas","volume":"98","author":"Saunders","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.6910","article-title":"CCAAT\/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein","volume":"179","author":"Pennini","year":"2007","journal-title":"J Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160340","article-title":"Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-gamma-mediated host defenses","volume":"213","author":"Gay","year":"2016","journal-title":"J Exp Med"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2387","article-title":"Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy","volume":"8","author":"Behar","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00171","article-title":"MptpB promotes mycobacteria survival by inhibiting the expression of inflammatory mediators and cell apoptosis in macrophages","volume":"8","author":"Fan","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.pt.2024.07.013","article-title":"The immunomicrotope of Leishmania control and persistence","volume":"40","author":"Bogdan","year":"2024","journal-title":"Trends Parasitol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90334-4","article-title":"Signal transduction by lymphocyte antigen receptors","volume":"76","author":"Weiss","year":"1994","journal-title":"Cell"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx6489","article-title":"Metabolism-driven posttranslational modifications and immune regulation: emerging targets for immunotherapy","volume":"11","author":"Wu","year":"2025","journal-title":"Sci Adv"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2026.1748470","article-title":"Rewriting the viral script: post-translational modifications orchestrating SARS-CoV-2 pathogenesis and immune evasion","volume":"17","author":"Qu","year":"2026","journal-title":"Front Microbiol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tibs.2025.07.006","article-title":"PTMs as molecular encoders: reprogramming chaperones into epichaperomes for network control in disease","volume":"50","author":"Chu","year":"2025","journal-title":"Trends Biochem Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062980","article-title":"Epigenetic regulation of glycosylation in cancer and other diseases","volume":"22","author":"Indellicato","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nature08746","article-title":"TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity","volume":"463","author":"Huppa","year":"2010","journal-title":"Nature"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.30.697079","article-title":"Discover potential new epitopes through post-translational modification in Sjogren's disease","author":"Li","year":"2025","journal-title":"Biorxiv"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13123013","article-title":"Post-translational modifications: key \"regulators\" of pancreatic cancer Malignant phenotype-advances in mechanisms and targeted therapies","volume":"13","author":"Shi","year":"2025","journal-title":"Biomedicines"},{"key":"B172","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","article-title":"Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation","volume":"186","author":"Geffen","year":"2023","journal-title":"Cell"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/s41467-025-57993-2","article-title":"Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites","volume":"16","author":"Jiang","year":"2025","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:21:26Z","timestamp":1790245286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1824717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":173,"alternative-id":["10.3389\/fimmu.2026.1824717"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1824717","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1824717"}}